Industry Research Reports
Global Human Prothrombin Complex Market Research Report 2026
Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 117 Pages
Report ld: 5534745
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2026-2032
11.8%
Market Size,2032
USD 4,702
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,408 million
Market Forecast in 2032(Value)
US$ 4,702 million
CAGR
11.8%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Prothrombin Complex competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report delivers a comprehensive overview of the global Human Prothrombin Complex market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Prothrombin Complex. The Human Prothrombin Complex market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Prothrombin Complex manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human Prothrombin Complex manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human Prothrombin Complex sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human Prothrombin Complex Market Overview
1.1 Product Definition
1.2 Human Prothrombin Complex by Type
1.2.1 Global Human Prothrombin Complex Market Value by Type: 2025 vs 2032
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex by Application
1.3.1 Global Human Prothrombin Complex Market Value by Application: 2025 vs 2032
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Size Estimates and Forecasts
1.4.1 Global Human Prothrombin Complex Revenue 2021–2032
1.4.2 Global Human Prothrombin Complex Sales 2021–2032
1.4.3 Global Human Prothrombin Complex Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Prothrombin Complex Market Competition by Manufacturers
2.1 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Prothrombin Complex Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Prothrombin Complex, Product Types and Applications
2.7 Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into the Industry
2.8 Global Human Prothrombin Complex Market Competitive Situation and Trends
2.8.1 Global Human Prothrombin Complex Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Prothrombin Complex Players Market Share by Revenue
2.8.3 Global Human Prothrombin Complex Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Prothrombin Complex Market Scenario by Region
3.1 Global Human Prothrombin Complex Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Prothrombin Complex Sales by Region: 2021–2032
3.2.1 Global Human Prothrombin Complex Sales by Region: 2021–2026
3.2.2 Global Human Prothrombin Complex Sales by Region: 2027–2032
3.3 Global Human Prothrombin Complex Revenue by Region: 2021–2032
3.3.1 Global Human Prothrombin Complex Revenue by Region: 2021–2026
3.3.2 Global Human Prothrombin Complex Revenue by Region: 2027–2032
3.4 North America Human Prothrombin Complex Market Facts & Figures by Country
3.4.1 North America Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Prothrombin Complex Sales by Country (2021–2032)
3.4.3 North America Human Prothrombin Complex Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Prothrombin Complex Market Facts & Figures by Country
3.5.1 Europe Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Prothrombin Complex Sales by Country (2021–2032)
3.5.3 Europe Human Prothrombin Complex Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Prothrombin Complex Market Facts & Figures by Region
3.6.1 Asia Pacific Human Prothrombin Complex Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Prothrombin Complex Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Prothrombin Complex Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Prothrombin Complex Market Facts & Figures by Country
3.7.1 Latin America Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Prothrombin Complex Sales by Country (2021–2032)
3.7.3 Latin America Human Prothrombin Complex Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Prothrombin Complex Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Prothrombin Complex Sales by Type (2021–2032)
4.1.1 Global Human Prothrombin Complex Sales by Type (2021–2026)
4.1.2 Global Human Prothrombin Complex Sales by Type (2027–2032)
4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2021–2032)
4.2 Global Human Prothrombin Complex Revenue by Type (2021–2032)
4.2.1 Global Human Prothrombin Complex Revenue by Type (2021–2026)
4.2.2 Global Human Prothrombin Complex Revenue by Type (2027–2032)
4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2021–2032)
4.3 Global Human Prothrombin Complex Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Prothrombin Complex Sales by Application (2021–2032)
5.1.1 Global Human Prothrombin Complex Sales by Application (2021–2026)
5.1.2 Global Human Prothrombin Complex Sales by Application (2027–2032)
5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2021–2032)
5.2 Global Human Prothrombin Complex Revenue by Application (2021–2032)
5.2.1 Global Human Prothrombin Complex Revenue by Application (2021–2026)
5.2.2 Global Human Prothrombin Complex Revenue by Application (2027–2032)
5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2021–2032)
5.3 Global Human Prothrombin Complex Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Human Prothrombin Complex Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CSL Human Prothrombin Complex Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grifols Human Prothrombin Complex Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Biological
6.5.1 Hualan Biological Company Information
6.5.2 Hualan Biological Description and Business Overview
6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
6.5.5 Hualan Biological Recent Developments/Updates
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Company Information
6.6.2 Meheco Xinxing Pharma Description and Business Overview
6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Prothrombin Complex Industry Chain Analysis
7.2 Human Prothrombin Complex Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Prothrombin Complex Production Mode & Process Analysis
7.4 Human Prothrombin Complex Sales and Marketing
7.4.1 Human Prothrombin Complex Sales Channels
7.4.2 Human Prothrombin Complex Distributors
7.5 Human Prothrombin Complex Customer Analysis
8 Human Prothrombin Complex Market Dynamics
8.1 Human Prothrombin Complex Industry Trends
8.2 Human Prothrombin Complex Market Drivers
8.3 Human Prothrombin Complex Market Challenges
8.4 Human Prothrombin Complex Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Human Prothrombin Complex Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Human Prothrombin Complex Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Human Prothrombin Complex Market Competitive Situation by Manufacturers in 2025
Table 4. Global Human Prothrombin Complex Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Human Prothrombin Complex Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Human Prothrombin Complex Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Human Prothrombin Complex Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Human Prothrombin Complex Average Price (M USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Human Prothrombin Complex, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Human Prothrombin Complex, Product Types and Applications
Table 12. Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Prothrombin Complex Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Prothrombin Complex Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Human Prothrombin Complex Sales by Region (K Units), 2021–2026
Table 18. Global Human Prothrombin Complex Sales Market Share by Region (2021–2026)
Table 19. Global Human Prothrombin Complex Sales by Region (K Units), 2027–2032
Table 20. Global Human Prothrombin Complex Sales Market Share by Region (2027–2032)
Table 21. Global Human Prothrombin Complex Revenue by Region (US$ Million), 2021–2026
Table 22. Global Human Prothrombin Complex Revenue Market Share by Region (2021–2026)
Table 23. Global Human Prothrombin Complex Revenue by Region (US$ Million), 2027–2032
Table 24. Global Human Prothrombin Complex Revenue Market Share by Region (2027–2032)
Table 25. North America Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Human Prothrombin Complex Sales by Country (K Units), 2021–2026
Table 27. North America Human Prothrombin Complex Sales by Country (K Units), 2027–2032
Table 28. North America Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
Table 29. North America Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Human Prothrombin Complex Sales by Country (K Units), 2021–2026
Table 32. Europe Human Prothrombin Complex Sales by Country (K Units), 2027–2032
Table 33. Europe Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Human Prothrombin Complex Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Human Prothrombin Complex Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Human Prothrombin Complex Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Human Prothrombin Complex Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Human Prothrombin Complex Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Human Prothrombin Complex Sales by Country (K Units), 2021–2026
Table 42. Latin America Human Prothrombin Complex Sales by Country (K Units), 2027–2032
Table 43. Latin America Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Human Prothrombin Complex Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Human Prothrombin Complex Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
Table 50. Global Human Prothrombin Complex Sales (K Units) by Type (2021–2026)
Table 51. Global Human Prothrombin Complex Sales (K Units) by Type (2027–2032)
Table 52. Global Human Prothrombin Complex Sales Market Share by Type (2021–2026)
Table 53. Global Human Prothrombin Complex Sales Market Share by Type (2027–2032)
Table 54. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Human Prothrombin Complex Revenue Market Share by Type (2021–2026)
Table 57. Global Human Prothrombin Complex Revenue Market Share by Type (2027–2032)
Table 58. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2021–2026)
Table 59. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2027–2032)
Table 60. Global Human Prothrombin Complex Sales (K Units) by Application (2021–2026)
Table 61. Global Human Prothrombin Complex Sales (K Units) by Application (2027–2032)
Table 62. Global Human Prothrombin Complex Sales Market Share by Application (2021–2026)
Table 63. Global Human Prothrombin Complex Sales Market Share by Application (2027–2032)
Table 64. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Human Prothrombin Complex Revenue Market Share by Application (2021–2026)
Table 67. Global Human Prothrombin Complex Revenue Market Share by Application (2027–2032)
Table 68. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2021–2026)
Table 69. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2027–2032)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 73. Takeda Human Prothrombin Complex Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 78. CSL Human Prothrombin Complex Product
Table 79. CSL Recent Developments/Updates
Table 80. Grifols Company Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 83. Grifols Human Prothrombin Complex Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 88. Octapharma Human Prothrombin Complex Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Hualan Biological Company Information
Table 91. Hualan Biological Description and Business Overview
Table 92. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 93. Hualan Biological Human Prothrombin Complex Product
Table 94. Hualan Biological Recent Developments/Updates
Table 95. Meheco Xinxing Pharma Company Information
Table 96. Meheco Xinxing Pharma Description and Business Overview
Table 97. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
Table 98. Meheco Xinxing Pharma Human Prothrombin Complex Product
Table 99. Meheco Xinxing Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Human Prothrombin Complex Distributors List
Table 103. Human Prothrombin Complex Customers List
Table 104. Human Prothrombin Complex Market Trends
Table 105. Human Prothrombin Complex Market Drivers
Table 106. Human Prothrombin Complex Market Challenges
Table 107. Human Prothrombin Complex Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Prothrombin Complex
Figure 2. Global Human Prothrombin Complex Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Human Prothrombin Complex Market Share by Type: 2025 & 2032
Figure 4. 500 IU/Vial Product Picture
Figure 5. 600 IU/Vial Product Picture
Figure 6. 1000 IU/Vial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Prothrombin Complex Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Human Prothrombin Complex Market Share by Application: 2025 & 2032
Figure 10. Hemophilia B
Figure 11. Vitamin K Deficiency
Figure 12. Others
Figure 13. Global Human Prothrombin Complex Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Human Prothrombin Complex Market Size (US$ Million), 2021–2032
Figure 15. Global Human Prothrombin Complex Sales (K Units), 2021–2032
Figure 16. Global Human Prothrombin Complex Average Price (M USD/Unit), 2021–2032
Figure 17. Human Prothrombin Complex Report Years Considered
Figure 18. Human Prothrombin Complex Sales Share by Manufacturers in 2025
Figure 19. Global Human Prothrombin Complex Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Human Prothrombin Complex Players: Market Share by Revenue in Human Prothrombin Complex in 2025
Figure 21. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Human Prothrombin Complex Sales Market Share by Country (2021–2032)
Figure 24. North America Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
Figure 25. U.S. Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Human Prothrombin Complex Sales Market Share by Country (2021–2032)
Figure 28. Europe Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
Figure 29. Germany Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Human Prothrombin Complex Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Human Prothrombin Complex Revenue Market Share by Region (2021–2032)
Figure 36. China Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Human Prothrombin Complex Sales Market Share by Country (2021–2032)
Figure 46. Latin America Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Human Prothrombin Complex by Type (2021–2032)
Figure 56. Global Revenue Market Share of Human Prothrombin Complex by Type (2021–2032)
Figure 57. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Human Prothrombin Complex by Application (2021–2032)
Figure 59. Global Revenue Market Share of Human Prothrombin Complex by Application (2021–2032)
Figure 60. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2021–2032)
Figure 61. Human Prothrombin Complex Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2026 to 2032?
The annual compound growth rate of the global Human Prothrombin Complex market is 11.8% 2026 to 2032.
Which companies rank high in the global Human Prothrombin Complex market?
What was the global market size of Human Prothrombin Complex in 2026?
Which region is expected to have the highest market share?
What was the global market size of Human Prothrombin Complex in 2032?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now